Please login to the form below

Not currently logged in
Email:
Password:

patents

This page shows the latest patents news and features for those working in and with pharma, biotech and healthcare.

FDA adcomm split on Sanofi’s type 1 diabetes drug

FDA adcomm split on Sanofi’s type 1 diabetes drug

It is also a key element in Sanofi’s plans to rebuild its diabetes franchise after the loss of patent protection for big-selling basal insulin Lantus (insulin glargine), which has

Latest news

More from news
Approximately 68 fully matching, plus 1,449 partially matching documents found.

Latest Intelligence

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    A new cliff is looming: Between 2018 and 2025, branded drugs worth more than $250bn in sales will see their patents expire.

  • Is China ready for a pharmaceutical gold rush?

    A lack of clear patent rules and regulatory transparency, as well as large-scale drug counterfeiting, gave rise to the perception that China’s market was difficult to navigate.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on ... revenue growth after years of patent-expiry-induced decline

  • Deal Watch October 2018

    The termination comes as a consequence of patent infringement litigation which has placed a stay on the FDA’s approval of the biosimilar, Lusduna Nexvue, in the US. ... non‐biologic product post‐patent loss, highlighting the benefits of biologics

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... Angela Hwang had headed the previous Essential Medicines division. She

More from intelligence
Approximately 2 fully matching, plus 110 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 35 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics